Abiopharma

🔍 Firestone Jeffrey D. (Executive)

Company: RXO, Inc. (RXO)

Report Date: 2026-08-22

Detailed Transactions and Holdings:

• Acquired 25,716 shares of Common Stock (Direct)
  Date: 2026-08-22 | Code: M | equity_swap_involved: 0 | shares_owned_after: 128,448.00 | transaction_form_type: 4
• Sold 11,172 shares of Common Stock at $22.54 per share (Direct)
  Date: 2026-08-22 | Code: F | equity_swap_involved: 0 | shares_owned_after: 117,276.00 | transaction_form_type: 4 | Footnotes: F1, F1
• Sold 25,716 shares of Restricted Stock Unit (Derivative)
  Date: 2026-08-22 | Code: M | equity_swap_involved: 0 | shares_owned_after: 109,178.00 | transaction_form_type: 4 | Footnotes: F2, F3, F3

Footnotes:

• F1: No shares were sold by the Reporting Person. These shares were withheld by the Issuer to fund tax liability attributable to the vesting and settlement of the Restricted Stock Units ("RSUs") reported on this Form 4. These RSUs vested and were settled as originally scheduled, and there were no related discretionary transactions or open market sales.
• F2: Each RSU represents a contingent right to receive, upon settlement, either (i) one share of Common Stock or (ii) a cash payment equal to the fair market value of one share of Common Stock.
• F3: The RSUs vest on the first five anniversaries of the grant date, generally subject to the Reporting Person's continued employment with the Issuer through the applicable vesting date.